Join our daily newsletter At The Bell to receive exclusive market insights
The ASX200 has been up 0.26% at 8,236 points.
The gains have been less than expected amid investor caution about a potential negative reaction by China’s markets to vague stimulus announcements on the weekend.
Back home, CBA’s head of Australian economics says several surveys indicate the disinflationary process has gathered momentum in the September quarter. However, the Q3 CPI data on October 30 is regarded as the strongest inflation indicator.
Sectors are a mixed bag. Materials are leading strongly, up 2.25%, followed by Health Care, up 0.64% and Financials up 0.34%.
Discretionary is the worst performer, down 1%, followed by IT, down 0.7% and Utilities, 0.4%.
Company News
Power and communications infrastructure provider GenusPlus (ASX:GNP) has been up nearly 2% on news its buying Partum Engineering. The binding conditional deal is worth $16 million.
Genus Plus has been $2.64.
Lincoln Minerals (ASX:LML) is set to kick off fieldwork sampling exploration work at its Yallunda uranium play in South Australia.
Lincoln Minerals has been trading at six tenths of a cent.
LTR Pharma (ASX:LTP) has been down half a percent 0.52% on final study results showing its ‘nasal viagra’ drug SPONTAN is absorbed 470% faster than oral tablets.
LTR Pharma has been $1.92.
-1200x645-380x200.jpg)
-1200x645-380x200.jpg)